Biology of Blood and Marrow Transplantation
Volume 14, Issue 7 , Pages 729-740 , July 2008

In Utero Hematopoietic Stem Cell Transplantation: Progress toward Clinical Application

  • Demetri Merianos
    • ,
  • Todd Heaton
    • ,
  • Alan W. Flake

      Affiliations

    • Corresponding Author InformationCorrespondence and reprint requests: Alan W. Flake, MD, Department of Surgery Abramson Research Bldg., Rm. 1116B, 3615 Civic Center Blvd., Philadelphia, PA 19104-4318.

Received 28 January 2008 ,Accepted 15 February 2008.

References 

  1. Billingham R, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature. 1953;172:603–607
  2. Palmer E. Negative selection—clearing out the bad apples from the T-cell repertoire. Nat Rev Immunol. 2003;3:383–391
  3. Sprent J. Central tolerance of T cells. Int Rev Immunol. 1995;13:95–105
  4. Takahama Y. Journey through the thymus: stromal guides for T-cell development and selection. Nat Rev Immunol. 2006;6:127–135
  5. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155:1151–1164
  6. Takahashi T, Tagami T, Yamazaki S, et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med. 2000;192:303–310
  7. Ziegler SF. FOXP3: of mice and men. Annu Rev Immunol. 2006;24:209–226
  8. Christensen JL, Wright DE, Wagers AJ, Weissman IL. Circulation and chemotaxis of fetal hematopoietic stem cells. PLoS Biol. 2004;2:E75
  9. Medvinsky A, Dzierzak E. Definitive hematopoiesis is autonomously initiated by the AGM region. Cell. 1996;86:897–906
  10. Mikkola HK, Gekas C, Orkin SH, Dieterlen-Lievre F. Placenta as a site for hematopoietic stem cell development. Exp Hematol. 2005;33:1048–1054
  11. Gill T. Chimerism in humans. Transplant Proc. 1977;9:1423–1431
  12. Jolly RD, Thompson KG, Murphy CE, Manktelow BW, Bruere AN, Winchester BG. Enzyme replacement therapy—an experiment of nature in a chimeric mannosidosis calf. Pediatr Res. 1976;10:219–224
  13. Owen RD. Immunogenetic consequences of vascular anastomoses between bovine cattle twins. Science. 1945;102:400–401
  14. Picus J, Aldrich WR, Letvin NL. A naturally occurring bone-marrow-chimeric primate. I. Integrity of its immune system. Transplantation. 1985;39:297–303
  15. Cragle R, Stone W. Preliminary results of kidney grafts between cattle chimeric twins. Transplantation. 1967;5:328–335
  16. Emery D, McCullagh P. Immunological reactivity between chimeric cattle twins. III. Mixed leukocyte reaction. Transplantation. 1980;29:17–22
  17. van Dijk B, Bommsma D, de Man A. Blood group chimerism in human multiple births is not rare. Am J Med Genet. 1996;61:264–268
  18. Picus J, Holley K, Aldrich WR, Griffin JD, Letvin NL. A naturally occurring bone marrow-chimeric primate. II. Environment dictates restriction on cytolytic T lymphocyte-target cell interactions. J Exp Med. 1985;162:2035–2052
  19. Hansen HE, Niebuhr E, Lomas C. Chimeric twins. T.S. and M.R. reexamined. Hum Hered. 1984;34:127–130
  20. Fleischman R, Mintz B. Prevention of genetic anemias in mice by microinjection of normal hematopoietic cells into the fetal placenta. Proc Natl Acad Sci USA. 1979;76:5736–5740
  21. Blazar BR, Taylor PA, Vallera DA. Adult bone marrow-derived pluripotent hematopoietic stem cells are engraftable when transferred in utero into moderately anemic fetal recipients. Blood. 1995;85:833–841
  22. Blazar BR, Taylor PA, Vallera DA. In utero transfer of adult bone marrow cells into recipients with severe combined immunodeficiency disorder yields lymphoid progeny with T- and B-cell functional capabilities. Blood. 1995;86:4353–4366
  23. Blazer BR, Taylor PA, McElmurry R, et al. Engraftment of severe combined immune deficient mice receiving allogeneic bone marrow via in utero or postnatal transfer. Blood. 1998;92:3949–3959
  24. Shultz LD, Schweitzer PA, Christianson SW, et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol. 1995;154:180–191
  25. Archer DR, Turner CW, Yeager AM, Fleming WH. Sustained multilineage engraftment of allogeneic hematopoietic stem cells in NOD/SCID mice after in utero transplantation. Blood. 1997;90:3222–3229
  26. Flake AW, Harrison MR, Adzick NS, Zanjani ED. Transplantation of fetal hematopoietic stem cells in utero: the creation of hematopoietic chimeras. Science. 1986;233:776–778
  27. Zanjani ED, Ascensao JL, Flake AW, Harrison MR, Tavassoli M. The fetus as an optimal donor and recipient of hemopoietic stem cells. Bone Marrow Transplant. 1992;10(Suppl 1):107–114
  28. Zanjani ED, Flake AW, Rice H, Hedrick M, Tavassoli M. Long-term repopulating ability of xenogeneic transplanted human fetal liver hematopoietic stem cells in sheep. J Clin Invest. 1994;93:1051–1055
  29. Zanjani ED, Pallavicini MG, Flake AW, et al. Engraftment and long-term expression of human fetal hemopoietic stem cells in sheep following transplantation in utero. J Clin Invest. 1992;89:1178–1188
  30. Lee PW, Cina RA, Randolph MA, et al. Stable multilineage chimerism across full MHC barriers without graft-versus-host disease following in utero bone marrow transplantation in pigs. Exp Hematol. 2005;33:371–379
  31. Lee PW, Cina RA, Randolph MA, et al. In utero bone marrow transplantation induces kidney allograft tolerance across a full major histocompatibility complex barrier in Swine. Transplantation. 2005;79:1084–1090
  32. Harrison MR, Slotnick RN, Crombleholme TM, Golbus MS, Tarantal AF, Zanjani ED. In-utero transplantation of fetal liver haemopoietic stem cells in monkeys. Lancet. 1989;2:1425–1427
  33. Shields LE, Bryant EM, Easterling TR, Andrews RG. Fetal liver cell transplantation for the creation of lymphohematopoietic chimerism in fetal baboons. Am J Obstet Gynecol. 1995;173:1157–1160
  34. Pearce R, Kiehm D, Armstrong D, et al. Induction of hematopoietic chimerism in the caprine fetus by intraperitoneal injection of fetal liver cells. Experientia. 1989;45:307–308
  35. Blakemore K, Hattenburg C, Stetten G, et al. In utero hematopoietic stem cell transplantation with haploidentical donor adult bone marrow in a canine model. Am J Obstet Gynecol. 2004;190:960–973
  36. Carrier E, Lee TH, Busch MP, Cowan MJ. Induction of tolerance in nondefective mice after in utero transplantation of major histocompatibility complex-mismatched fetal hematopoietic stem cells. Blood. 1995;86:4681–4690
  37. Donahue J, Gilpin E, Lee TH, Busch MP, Croft M, Carrier E. Microchimerism does not induce tolerance and sustains immunity after in utero transplantation. Transplantation. 2001;71:359–368
  38. Kim HB, Shaaban AF, Yang EY, Liechty KW, Flake AW. Microchimerism and tolerance after in utero bone marrow transplantation in mice. J Surg Res. 1998;77:1–5
  39. Hayashi S, Hsieh M, Peranteau WH, Ashizuka S, Flake AW. Complete allogeneic hematopoietic chimerism achieved by in utero hematopoietic cell transplantation and cotransplantation of LLME-treated, MHC-sensitized donor lymphocytes. Exp Hematol. 2004;32:290–299
  40. Hayashi S, Abdulmalik O, Peranteau WH, et al. Mixed chimerism following in utero hematopoietic stem cell transplantation in murine models of hemoglobinopathy. Exp Hematol. 2003;31:176–184
  41. Shaaban AF, Kim HB, Milner R, Flake AW. A kinetic model for the homing and migration of prenatally transplanted marrow. Blood. 1999;94:3251–3257
  42. Kim HB, Shaaban AF, Milner R, Fichter C, Flake AW. In utero bone marrow transplantation induces tolerance by a combination of clonal deletion and anergy. J Pediatr Surg. 1999;34:726–730
  43. Hayashi S, Peranteau WH, Shaaban AF, Flake AW. Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion. Blood. 2002;100:804–812
  44. Peranteau WF, Hayashi S, Hsieh M, Shaaban AF, Flake AW. High level allogeneic chimerism achieved by prenatal tolerance induction and postnatal non-myeloablative bone marrow transplantation. Blood. 2002;100:2225–2234
  45. Ashizuka S, Peranteau WH, Hayashi S, Flake AW. Busulfan-conditioned bone marrow transplantation results in high-level allogeneic chimerism in mice made tolerant by in utero hematopoietic cell transplantation. Exp Hematol. 2006;34:359–368
  46. Flake AW, Zanjani ED. In utero hematopoietic stem cell transplantation: ontogenic opportunities and biologic barriers. Blood. 1999;94:2179–2191
  47. Rao SS, Peters SO, Crittenden RB, Stewart FM, Ramshaw HS, Quesenberry PJ. Stem cell transplantation in the normal nonmyeloablated host: relationship between cell dose, schedule, and engraftment. Exp Hematol. 1997;25:114–121
  48. Stewart FM, Crittenden RB, Lowry PA, Pearson-White S, Quesenberry PJ. Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice. Blood. 1993;81:2566–2571
  49. Ramshaw HS, Crittenden RB, Dooner M, Peters SO, Rao SS, Quesenberry PJ. High levels of engraftment with a single infusion of bone marrow cells into normal unprepared mice. Biol Blood Marrow Transplant. 1995;1:74–80
  50. Peranteau WH, Endo M, Adibe OO, Flake AW. Evidence for an immune barrier after in utero hematopoietic-cell transplantation. Blood. 2007;109:1331–1333
  51. Peranteau WH, Endo M, Adibe OO, Merchant A, Zoltick PW, Flake AW. CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation. Blood. 2006;108:4268–4274
  52. Wolf NS, Bertoncello I, Jiang D, Priestley G. Developmental hematopoiesis from prenatal to young-adult life in the mouse model. Exp Hematol. 1995;23:142–146
  53. Harrison DE, Astle CM. Short- and long-term multilineage repopulating hematopoietic stem cells in late fetal and newborn mice: models for human umbilical cord blood transplantation. Blood. 1997;90:174–181
  54. Mintz B, Anthony K, Litwin S. Monoclonal derivation of mouse myeloid and lymphoid lineages from totipotent hematopoietic stem cells experimentally engrafted in fetal hosts. Proc Natl Acad Sci USA. 1984;81:7835–7839
  55. Harrison DE, Zhong RK, Jordan CT, Lemischka IR, Astle CM. Relative to adult marrow, fetal liver repopulates nearly 5 times more effectively long-term than short-term. Exp Hematol. 1997;25:293–297
  56. Jordan CT, Astle CM, Zawadzki J, Mackarehtschian K, Lemischka IR, Harrison DE. Long-term repopulating abilities of enriched fetal liver stem cells measured by competitive repopulation. Exp Hematol. 1995;23:1011–1015
  57. Rebel VI, Miller CL, Eaves CJ, Lansdorp PM. The repopulating potential of fetal liver hematopoietic stem cells in mice exceeds that of their liver adult bone marrow counterparts. Blood. 1996;87:3500–3507
  58. Rebel VI, Miller CL, Thornbury GR, Dragowska WH, Eaves CJ, Lansdorp PM. A comparison of long-term repopulating hematopoietic stem cells in fetal liver and adult bone marrow from the mouse. Exp Hematol. 1996;24:638–648
  59. Leung W, Ramirez M, Civin CI. Quantity and quality of engrafting cells in cord blood and autologous mobilized peripheral blood. Biol Blood Marrow Transplant. 1999;5:69–76
  60. Rosler ES, Brandt JE, Chute J, Hoffman R. An in vivo competitive repopulation assay for various sources of human hematopoietic stem cells. Blood. 2000;96:3414–3421
  61. Van Zant G, Chen JJ, Scott-Micus K. Developmental potential of hematopoietic stem cells determined using retrovirally marked allophenic marrow. Blood. 1991;77:756–763
  62. Van Zant G, Holland BP, Eldridge PW, Chen JJ. Genotype-restricted growth and aging patterns in hematopoietic stem cell populations of allophenic mice. J Exp Med. 1990;171:1547–1565
  63. Mintz B, Palm J. Gene control of hematopoiesis. I. Erythrocyte mosaicism and permanent immunological tolerance in allophenic mice. J Exp Med. 1969;129:1013–1027
  64. Stewart FM, Zhong S, Wuu J, Hsieh C-c, Nilsson SK, Quesenberry PJ. Lymphohematopoietic engraftment in minimally myeloablated hosts. Blood. 1998;91:3681–3687
  65. Flake A, Roncarolo M-G, Puck J, et al. Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med. 1996;335:1806–1810
  66. Touraine JL, Raudrant D, Rebaud A, et al. In utero transplantation of stem cells in humans: immunological aspects and clinical follow-up of patients. Bone Marrow Transplant. 1992;1:121–126
  67. Touraine JL, Raudrant D, Royo C, et al. In-utero transplantation of stem cells in bare lymphocyte syndrome. Lancet. 1989;1:1382
  68. Westgren M, Ringden O, Bartmann P, et al. Prenatal T-cell reconstitution after in utero transplantation with fetal liver cells in a patient with X-linked severe combined immunodeficiency. Am J Obstet Gynecol. 2002;187:475–482
  69. Renda MC, Fecarotta E, Dieli F, et al. Evidence of alloreactive T lymphocytes in fetal liver: implications for fetal hematopoietic stem cell transplantation. Bone Marrow Transplant. 2000;25:135–141
  70. Lindton B, Markling L, Ringden O, Kjaeldgaard A, Gustafson O, Westgren M. Mixed lymphocyte culture of human fetal liver cells. Fetal Diagn Ther. 2000;15:71–78
  71. Toivanen P, Uksila J, Leino A, Lassila O, Hirvonen T, Ruuskanen O. Development of mitogen responding T cells and natural killer cells in the human fetus. Immunol Rev. 1981;57:89–105
  72. Lindton B, Markling L, Ringden O, Westgren M. In vitro studies of the role of CD3+ and CD56+ cells in fetal liver cell alloreactivity. Transplantation. 2003;76:204–209
  73. Gotherstrom C, Johnsson AM, Mattsson J, Papadogiannakis N, Westgren M. Identification of maternal hematopoietic cells in a 2nd-trimester fetus. Fetal Diagn Ther. 2005;20:355–358
  74. Setiady YY, Samy ET, Tung KS. Maternal autoantibody triggers de novo T cell-mediated neonatal autoimmune disease. J Immunol. 2003;170:4656–4664
  75. Shields LE, Gaur L, Delio P, Potter J, Sieverkropp A, Andrews RG. Fetal immune suppression as adjunctive therapy for in utero hematopoietic stem cell transplantation in nonhuman primates. Stem Cells. 2004;22:759–769
  76. Fleischman RA, Mintz B. Development of adult bone marrow stem cells in H-2 compatable and noncompatable mouse fetuses. J Exp Med. 1984;159:159–169
  77. Howson-Jan K, Matloub YH, Vallera DA, Blazar BR. In utero engraftment of fully H-2-incompatible versus congenic adult bone marrow transferred into nonanemic or anemic murine fetal recipients. Transplantation. 1993;56:709–716
  78. Barker JE, Schuldt AJ, Lessard MD, Jude CD, Vogler CA, Soper BW. Donor cell replacement in mice transplanted in utero is limited by immune-independent mechanisms. Blood Cells Mol Dis. 2003;3:291–297
  79. Blackman M, Kappler J, Marrack P. The role of the T-cell receptor in positive and negative selection of developing T-cells. Science. 1990;248:1335–1342
  80. Schwartz R. Acquisition of immunologic self tolerance. Cell. 1989;57:1073–1081
  81. Sha WC, Nelson CA, et al. Positive and negative selection of an antigen receptor on T-cells in transgenic mice. Nature. 1988;336:73–76
  82. Touraine JL, Raudrant D, Golfier F, et al. Reappraisal of in utero stem cell transplantation based on long-term results. Fetal Diagn Ther. 2004;19:305–312
  83. Wengler G, Lanfranchi A, Frusca T, et al. In-utero transplantation of parental CD34 haematopoietic progenitor cells in a patient with X-linked severe combined immunodeficiency (SCIDX1). Lancet. 1996;348:1484–1487
  84. Buckley RH, Schiff SE, Schiff RI, et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med. 1999;340:508–516
  85. Flake AW, Zanjani ED. In utero hematopoietic stem cell transplantation. A status report. JAMA. 1997;278:932–937
  86. Jones DR, Bui TH, Anderson EM, et al. In utero haematopoietic stem cell transplantation: current perspectives and future potential. Bone Marrow Transplant. 1996;18:831–837
  87. Muench MO, Rae J, Barcena A, et al. Transplantation of a fetus with paternal Thy-1(+)CD34(+)cells for chronic granulomatous disease. Bone Marrow Transplant. 2001;27:355–364
  88. Westgren M. In utero stem cell transplantation. Semin Reprod Med. 2006;24:348–357
  89. Cowan M, Golbus M. In utero hematopoietic stem cell transplants for inherited disease. Am J Pediatr Hematol Oncol. 1994;16:35–42
  90. Diukman R, Golbus MS. In utero stem cell therapy. J Reprod Med. 1992;37:515–520
  91. Slavin S, Naparstek E, Ziegler M, et al. Clinical application of intrauterine bone marrow transplantation for treatment of genetic disease—feasibility studies. Bone Marrow Transplant. 1992;1:189–190
  92. Touraine J. Treatment of human fetuses and induction of immunological tolerance in humans by in utero transplantation of stem cells into fetal recipients. Acta Haematol. 1996;96:115–119
  93. Orlandi F, Giambona A, Messana F, et al. Evidence of induced non-tolerance in HLA-identical twins with hemoglobinopathy after in utero fetal transplantation. Bone Marrow Transplant. 1996;18:637–639
  94. Monni G, Ibba RM, Zoppi MA, Floris M. In utero stem cell transplantation. Croat Med J. 1998;39:220–223
  95. Hayward A, Ambruso D, Battaglia F, et al. Microchimerism and tolerance following intrauterine transplantation and transfusion for a-thalassemia-1. Fetal Diagn Ther. 1998;13:8–14
  96. Westgren M, Ringden O, Sturla E-N, et al. Lack of evidence of permanent engraftment after in utero fetal stem cell transplantation in congenital hemoglobinopathies. Transplantation. 1996;61:1176–1179
  97. Bambach BJ, Moser HW, Blakemore K, et al. Engraftment following in utero bone marrow transplantation for globoid cell leukodystrophy. Bone Marrow Transplant. 1997;19:399–402
  98. Touraine JL, Raudrant D, Laplace S. Transplantation of hemopoietic cells from the fetal liver to treat patients with congenital diseases postnatally or prenatally. Transplant Proc. 1997;29:712–713
  99. Flake AW, Zanjani ED. Treatment of severe combined immunodeficiency. Letter to the Editor. N Engl J Med. 1999;341:291
  100. Kvittingen EA, Rootwelt H, Brandtzaeg P, Bergan A, Berger R. Hereditary tyrosinemia type I. Self-induced correction of the fumarylacetoacetase defect. J Clin Invest. 1993;91:1816–1821
  101. Hirschhorn R, Yang DR, Puck JM, Huie ML, Jiang CK, Kurlandsky LE. Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency. Nat Genet. 1996;13:290–296
  102. D'Andrea AD, Grompe M. Molecular biology of Fanconi anemia: implications for diagnosis and therapy. Blood. 1997;90:1725–1736
  103. Ellis NA, Lennon DJ, Proytcheva M, Aldadeff B, Henderson EE, German J. Somatic intragenic recombination within the mutated locus BLM can correct the high sister-chromatid exchange phenotype of Bloom Syndrome cells. Am J Hum Genet. 1995;57:1019–1027
  104. Bjorgvinsdottir H, Ding C, Pech N, Gifford M, Li L, Dinauer M. Retroviral-mediated gene transfer of gp91phox into bone marrow cells rescues defect in host defense against Aspergillus fumigatus in murine X-linked chronic granulomatous disease. Blood. 1997;89:41–48
  105. Hollenbaugh D, Wu LH, Ochs HD, et al. The random inactivation of the X chromosome carrying the defective gene responsible for X-linked hyper IgM syndrome (X-HIM) in female carriers of HIGM1. J Clin Invest. 1994;94:616–622
  106. Anderson DC, Springer TA. Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150,95 glycoproteins. Annu Rev Med. 1987;38:175–194
  107. Creevy KE, Bauer TR, Tuschong LM, et al. Canine leukocyte adhesion deficiency colony for investigation of novel hematopoietic therapies. Vet Immunol Immunopathol. 2003;94:11–22
  108. Kishimoto TK, Hollander N, Roberts TM, Anderson DC, Springer TA. Heterogeneous mutations in the beta subunit common to the LFA-1, Mac-1, and p150,95 glycoproteins cause leukocyte adhesion deficiency. Cell. 1987;50:193–202
  109. Springer TA, Thompson WS, Miller LJ, Schmalstieg FC, Anderson DC. Inherited deficiency of the Mac-1, LFA-1, p150,95 glycoprotein family and its molecular basis. J Exp Med. 1984;160:1901–1918
  110. Bauer TR, Creevy KE, Gu YC, et al. Very low levels of donor CD18+ neutrophils following allogeneic hematopoietic stem cell transplantation reverse the disease phenotype in canine leukocyte adhesion deficiency. Blood. 2004;103:3582–3589
  111. Bauer TR, Gu YC, Tuschong LM, et al. Nonmyeloablative hematopoietic stem cell transplantation corrects the disease phenotype in the canine model of leukocyte adhesion deficiency. Exp Hematol. 2005;33:706–712
  112. Sokolic RA, Bauer TR, Gu YC, et al. Nonmyeloablative conditioning with busulfan before matched littermate bone marrow transplantation results in reversal of the disease phenotype in canine leukocyte adhesion deficiency. Biol Blood Marrow Transplant. 2005;11:755–763
  113. Peranteau WH, Gu Y, Volk S, et al. In utero hematopoietic cell transplantation using haploidentical parental donors reverses the lethal phenotype in dogs with canine leukocyte adhesion deficiency. Blood. 2006;108:188a
  114. Frattini A, Blair HC, Sacco MG, et al. Rescue of ATPa3-deficient murine malignant osteopetrosis by hematopoietic stem cell transplantation in utero. Proc Natl Acad Sci USA. 2005;102:14629–14634
  115. Le Blanc K, Gotherstrom C, Ringden O, et al. Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation. 2005;79:1607–1614
  116. Liechty KW, MacKenzie TC, Shaaban AF, et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med. 2000;6:1282–1286
  117. Dominici M, Pritchard C, Garlits JE, Hofmann TJ, Persons DA, Horwitz EM. Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation. Proc Natl Acad Sci USA. 2004;101:11761–11766
  118. Andreani M, Nesci S, Lucarelli G, et al. Long-term survival of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation. Bone Marrow Transplant. 2000;25:401–404
  119. Walters MC, Patience M, Leisenring W, et al. Bone marrow transplantation for sickle cell disease. [see comments] N Engl J Med. 1996;335:369–376
  120. Flake AW, Zanjani ED. In utero transplantation. In:  Bloom KG,  Forman SJ,  Applebaum FR editor. Thomas' Hematopoietic Cell Transplantation. 3rd ed.. Malden, MA: Blackwell Science Inc.; 2004;p. 565–575
  121. Christopherson KW, Hangoc G, Broxmeyer HE. Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells. J Immunol. 2002;169:7000–7008
  122. Shaaban AF, Kim HB, Gaur L, Liechty KW, Flake AW. Prenatal transplantation of cytokine-stimulated marrow improves early chimerism in a resistant strain combination but results in poor long-term engraftment. Exp Hematol. 2006;34:1278–1287
  123. Almeida-Porada G, Flake AW, Glimp HA, Zanjani ED. Co-transplantation of stroma results in enhancement of engraftment and early expression of donor hematopoietic stem cell in utero. Exp Hematol. 1999;27:1569–1575
  124. Almeida-Porada G, Flake AW, Zanjani ED. Cotransplantation of sheep stroma results in enhancement of engraftment and early expression of donor hematopoietic stem cells in utero. Blood. 1998;92(Suppl 1):116a
  125. Crombleholme TM, Harrison MR, Zanjani ED. In utero transplantation of hematopoietic stem cells in sheep: the role of T cells in engraftment and graft-versus-host disease. J Pediatr Surg. 1990;25:885–892
  126. Shields LE, Gaur LK, Gough M, Potter J, Sieverkropp A, Andrews RG. In utero hematopoietic stem cell transplantation in nonhuman primates: the role of T cells. Stem Cells. 2003;21:304–314
  127. Petersen SM, Gendelman M, Murphy KM, et al. Use of T-cell antibodies for donor dosaging in a canine model of in utero hematopoietic stem cell transplantation. Fetal Diagn Ther. 2007;22:175–179
  128. Bhattacharyya S, Chawla A, Smith K, et al. Multilineage engraftment with minimal graft-versus-host disease following in utero transplantation of S-59 psoralen/ultraviolet a light-treated, sensitized T cells and adult T cell-depleted bone marrow in fetal mice. J Immunol. 2002;169:6133–6140
  129. den Haan JM, Meadows LM, Wang W, et al. The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy. Science. 1998;279:1054–1057

 The authors have no potential conflicts of interest to disclose.

PII: S1083-8791(08)00089-X

doi: 10.1016/j.bbmt.2008.02.012

Biology of Blood and Marrow Transplantation
Volume 14, Issue 7 , Pages 729-740 , July 2008

Article Tools